Navigation Links
PAREXEL Reports Second Quarter Fiscal Year 2009 Financial Results
Date:1/26/2009

s approximately $2.0 billion at the end of the December quarter, an increase of approximately 13% year-over-year. The reported backlog included gross new business wins of $459.0 million, cancellations of $121.0 million (including $44 million from the previously mentioned client contract termination), and a negative impact from foreign exchange rates of $116.5 million. The net book-to-bill ratio was 1.23 in the quarter (defined as gross new business less cancellations divided by service revenue). Excluding the client contract termination, the net book-to-bill ratio was approximately 1.39.

Mr. Josef H. von Rickenbach, PAREXEL's Chairman and Chief Executive Officer stated, "During the second quarter, I was pleased with the Company's new business performance in a challenging market. We also made good progress with the integration of ClinPhone, which enabled us to drive significant sequential improvement in Perceptive's gross margin."

Mr. von Rickenbach continued, "With regard to our outlook for the current calendar year, I remain cautiously optimistic. While we may experience a slow-down in the small biopharma client segment due to the current condition of the financial markets, I believe that this impact may be offset by an increase in outsourcing levels from larger clients. In this regard, many large pharma companies are approaching clinical trials outsourcing more strategically, and look to benefit from our depth of expertise in the drug development process. Notwithstanding the current uncertain environment, we continue to believe that our strategy and position in the industry are sound, and feel that we are poised to take advantage of the many opportunities that continue to exist in the marketplace."

The Company issued forward-looking guidance for the third quarter of Fiscal Year 2009 (ending March 31, 2009), for Fiscal Year 2009 and for Calendar 2009 using recent exchange rates. For the third quarter, the
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. PAREXEL Announces Date of Second Quarter Fiscal Year 2009 Earnings Release and Conference Call
2. PAREXEL Reports Preliminary Second Quarter Results
3. PAREXEL International to Present at NASDAQ OMX 22nd Investor Program
4. PAREXEL Reports First Quarter Fiscal Year 2009 Financial Results
5. PAREXEL International to Present at Robert W. Bairds 2008 Growth Stock Conference
6. PAREXEL International to Present at Bank of America 2008 Smid Cap Conference
7. Matrixx Initiatives, Inc. Reports Third-Quarter Net Sales Increased 26% to $38.7 Million, Net Income Increased to $4.8 Million, or $0.50 Earnings Per Share
8. Quest Diagnostics Reports Growth in Revenue and Earnings for Fourth Quarter 2008 and Provides 2009 Guidance
9. Wyeth Reports Earnings Results for the 2008 Full Year and Fourth Quarter
10. MedPredict Publishes Two New Reports Providing Expert Analysis of Malignant Hematology Drug Development
11. Thomson Reuters Publishes Three Pharma Matters Reports Covering the Third Quarter of 2008
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... Washington, DC (PRWEB) September 17, 2014 ... family history. Along with regular screening and examination, a ... In this episode of Epicure with the Chef ... GWMFA Urologist Dr. Paul Rusilko to prepare a delicious ... in our western diets that influence risk of prostate ...
(Date:9/17/2014)... Neon Sport and Fitmark have an exclusive ... most anticipated event, Joe Weider's Olympia Fitness & Performance ... take home a Neon Sport branded Fitmark Power Duffel ... Fitmark will hold entries for the special prize at ... , “There’s nothing more exciting than seeing our collective ...
(Date:9/17/2014)... Acceleratio Ltd., an innovative software development ... of Server Monitoring Toolkit , a web ... It brings real-time server monitoring via a live ... enhanced features that significantly improve troubleshooting and detection ... agentless data collection, a user-friendly interface, and many ...
(Date:9/17/2014)... (PRWEB) September 17, 2014 Stand Up ... and music, returns to the Theater at Madison Square ... the Bob Woodruff Foundation (BWF) and New York Comedy ... returning service members, veterans and their families. , ... John Mulaney, John Oliver, Bruce Springsteen, Brian Williams and ...
(Date:9/17/2014)... 17, 2014 Kamut International is pleased ... key ingredient in Michael Angelo’s new “Made With Organic” ... fully organic lasagna ready made, frozen meal. Michael Angelo’s ... and these new products align well with Kamut International’s ... KAMUT® Brand wheat must be grown certified organic. , ...
Breaking Medicine News(10 mins):Health News:Boost Prostate Health with Epicure with the Chef MDs 2Health News:Electrifying Sports Nutrition Brand, Neon Sport, Pairs with Global Fitness Bag & Luggage Brand, Fitmark Bags, for an Exclusive Giveaway at Olympia Expo, This Weekend 2Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 2Health News:New Server Monitoring Toolkit v6 Brings Real-Time Windows Server Monitoring and New Server Reports 3Health News:Louis C.K., John Mulaney, John Oliver, Bruce Springsteen, Brian Williams & More to Perform at 8th Annual Stand Up for Heroes at Theater at Madison Square Garden, Nov. 5 2Health News:Louis C.K., John Mulaney, John Oliver, Bruce Springsteen, Brian Williams & More to Perform at 8th Annual Stand Up for Heroes at Theater at Madison Square Garden, Nov. 5 3Health News:Louis C.K., John Mulaney, John Oliver, Bruce Springsteen, Brian Williams & More to Perform at 8th Annual Stand Up for Heroes at Theater at Madison Square Garden, Nov. 5 4Health News:Louis C.K., John Mulaney, John Oliver, Bruce Springsteen, Brian Williams & More to Perform at 8th Annual Stand Up for Heroes at Theater at Madison Square Garden, Nov. 5 5Health News:KAMUT® Brand Wheat Delivers a High Quality Ingredient and Authentic Italian Taste for Michael Angelo’s New Ready-Made Meals featuring Organic Ingredients 2
... An international team of researchers says abortion stigma is ... women who,ve had abortions. As a result, they,re launching ... stigma surrounding abortion. Their invited paper, "Abortion ... published in the current journal, Women,s Health Issues ...
... people every day, are a surprisingly common cause of ... hospital after sustaining stepladder injuries, many of which resulted ... how improved design and user behavior can decrease the ... HFES 55th Annual Meeting presentation, "The Role of Human ...
... (HealthDay News) -- Many members of low-income families are not ... In assessing the families, eating patterns and the nutritional ... 70 percent of the 100 families, who were newly enrolled ... amounts of several vital nutrients, including vitamins A and C, ...
... sorafenib responded to the flu vaccine, which suggests the ... as previously feared, according to a study in ... Association for Cancer Research. Keith Flaherty, M.D., ... and a senior editor of Clinical Cancer Research, said ...
... of scheduling chemotherapy treatments has been substantially reduced by a ... from the Sauder School of Business at the University of ... Called Chemo SmartBook, the innovative new scheduling system ... from the Health Employers Association of British Columbia in the ...
... many, a tax on soda is a no-brainer in advancing the ... in recent years that conclude that sugary drinks have a lot ... obese people tend to drink diet sodas, and therefore taxing soft ... weapon in combating obesity, according to a new Northwestern University study. ...
Cached Medicine News:Health News:International team explores the stigma surrounding abortion 2Health News:Improved stepladder design may decrease injuries 2Health News:Low-Income Families Often Miss Out on Proper Nutrition 2Health News:Patients treated with sunitinib and sorafenib respond to flu vaccine 2Health News:Innovative UBC-BC Cancer Agency system reduces waitlisting for chemotherapy patients 2Health News:Innovative UBC-BC Cancer Agency system reduces waitlisting for chemotherapy patients 3Health News:Can soda tax curb obesity? 2
(Date:9/17/2014)... , Sept. 17, 2014   OTEMR, Inc. ... Edition Complete EHR certification, which designates that the software ... Stage 1 and Stage 2 Meaningful Use measures required ... Reinvestment Act (ARRA).  ONETOUCH EMR 2.0 was certified on ... Office of the National Coordinator-Authorized Certification Body (ONC-ACB) and ...
(Date:9/17/2014)... MUMBAI, India , September 17, 2014 ... TRPA1 antagonist, GRC 17536, has shown positive data in ... with painful diabetic neuropathy , ... Transient Receptor Potential Ankyrin 1 (TRPA1) antagonist, GRC 17536 ... blind, placebo controlled, multi-centre, proof of concept study conducted ...
(Date:9/17/2014)... 17, 2014  Bayer HealthCare will present data on ... th Annual Meeting, which takes place September 18-20 ... which will be shared through poster presentations, showcase Bayer,s ... Data will be presented in a scientific forum. ... in hemophilia A patients, Bayer is maintaining its commitment ...
Breaking Medicine Technology:OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 2OTEMR, Inc.'s ONETOUCH EMR Achieves ONC HIT 2014 Edition COMPLETE EHR Certification from ICSA Labs 3Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 2Glenmark's TRPA1 Antagonist 'GRC 17536' Shows Positive Data in a Proof of Concept Study 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 2Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 3Bayer to Present Data on Hemophilia Research at NHF in Washington, D.C. 4
... and SAN FRANCISCO , May 31 Dendreon Corporation ... the integrated analysis of four randomized PROVENGE® (sipuleucel-T) clinical trials of an ... of the American Urological Association (AUA) in San Francisco . ... "The approval of PROVENGE ...
... , May 28, 2010 Shire plc (LSE: SHP,NASDAQ: ... Paragraph IV Notice Letter today from Zydus,Pharmaceuticals USA, Inc. ("Zydus") advising of ... of Shire,s 1.2g,mesalamine delayed release tablets, LIALDA(R). , ... LIALDA is protected by the ...
Cached Medicine Technology:Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting 2Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting 3Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting 4Shire Receives LIALDA(R) Paragraph IV Notice Letter From Zydus Pharmaceuticals 2Shire Receives LIALDA(R) Paragraph IV Notice Letter From Zydus Pharmaceuticals 3
Agility has delivered a RFID-enabled mobile asset management program....
... VerdaSee Location-ID™ is a family of ... equipment and individuals inside hospitals, healthcare ... frequency technology. The target tracking areas ... a series of radio frequency identification ...
The WatchMate LC model is a cost-effective solution for monitoring a single exit, and provides local notification of an alarm....
Assetrac allows identification, location, and protection of your assets....
Medicine Products: